Found 46 matching trials
Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma PHASE2 Non-myeloablative approach for allogeneic transplant is a reasonable option...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs PHASE1 The Stanford Medical Center Program in Multi-Organ Transplantation and the ...
Show More Location
Stanford University, School of Medicine
Learn More & Join Trial
Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus PHASE1 The Stanford Medical Center Division of Immunology and Rheumatology and the...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer PHASE2 RATIONALE: Umbilical cord blood transplantation may allow doctors to give h...
Show More Location
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Learn More & Join Trial
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant PHASE2 RATIONALE: Giving low doses of chemotherapy, monoclonal antibodies, and rad...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer PHASE2 RATIONALE: Giving chemotherapy and total-body irradiation before a donor pe...
Show More Location
Banner Good Samaritan Medical Center
Learn More & Join Trial
Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies. PHASE2 The participants are being asked to take part in this clinical trial becaus...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings PHASE2 The present project aims at comparing two nonmyeloablative regimens current...
Show More Location
AZ Gasthuisberg Leuven
Learn More & Join Trial
Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation PHASE2 The purpose of this study is to evaluate whether addition of a low dose of ...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer PHASE2 RATIONALE: Giving chemotherapy drugs and total-body irradiation before a do...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial